Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 347.08M | $ 598.18M | 172.34% |
3/31/2025 | $ 324.03M | $ 594M | 183.32% |
12/31/2024 | $ 343.82M | $ 591.21M | 171.95% |
9/30/2024 | $ 314.11M | $ 559.59M | 178.15% |
6/30/2024 | $ 352.32M | $ 556.63M | 157.99% |
3/31/2024 | $ 373.06M | $ 548.87M | 147.13% |
12/31/2023 | $ 205.8M | $ 540.95M | 262.86% |
9/30/2023 | $ 221.31M | $ 531.53M | 240.18% |
6/30/2023 | $ 234.63M | $ 522.9M | 222.87% |
3/31/2023 | $ 251.82M | $ 513.22M | 203.81% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for ESPERION THERAPEUTICS INC is calculated as follows: Debt [ $ 177.91M ] / Assets [ $ 250.97M ]
(=) Debt to Assets [ 70.89% ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |